PSMB8 and non-small cell lung carcinoma: In breast cancer, NSCLC, bladder urothelial cancer, sarcoma, mesothelioma, melanoma and thymic cancer, elevated levels of PSMB8, 9 or 10 mRNA correlate with improved survival (7, 39, 43, 45, 49, 69, 75).